ALNYLAM PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2010 to Q1 2025.
  • Alnylam Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $8.97M, a 30.9% decline year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $34.3M, a 44.9% decline from 2023.
  • Alnylam Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $62.2M, a 13.7% decline from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $72.1M, a 5.65% decline from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

ALNYLAM PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $8.97M -$4M -30.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q1 2024 $13M -$918K -6.61% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q1 2023 $13.9M -$3.97M -22.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 $17.9M +$681K +3.96% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $17.2M -$2.44M -12.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q1 2020 $19.6M -$24.4M -55.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q1 2019 $44M +$22.8M +107% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $21.3M -$14.9M -41.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2017 $36.2M +$33.4M +1210% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q1 2016 $2.76M +$649K +30.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q1 2015 $2.11M +$1.72M +444% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q1 2014 $388K -$1.41M -78.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 $1.8M +$1.54M +584% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q1 2012 $263K +$235K +839% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q1 2011 $28K -$1.07M -97.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q1 2010 $1.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05

ALNYLAM PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $34.3M -$27.9M -44.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $62.2M -$9.85M -13.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $72.1M -$4.31M -5.65% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 $76.4M +$6.01M +8.54% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $70.4M -$69.8M -49.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $140M +$13.3M +10.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 $127M +$22.7M +21.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $104M +$39.7M +61.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $64.6M +$51.6M +399% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $13M +$3.99M +44.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $8.96M +$4.96M +124% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-15
2013 $4.01M -$4.34M -52% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 $8.35M +$7.06M +547% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 $1.29M -$3.44M -72.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 $4.73M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.